P
ELV icon

Pitcairn’s Elevance Health ELV Stock Holding History

Pitcairn’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,787
Closed -$577K – 174
2025
Q3 		$577K Sell
1,787
-334
-16% -$104K 0.05% 320
2025
Q2 		$825K Sell
2,121
-190
-8% -$76.4K 0.05% 296
2025
Q1 		$1.01M Buy
2,311
+4
+0.2% +$1.61K 0.06% 270
2024
Q4 		$851K Buy
2,307
+50
+2% +$20.9K 0.05% 290
2024
Q3 		$1.17M Sell
2,257
-472
-17% -$252K 0.07% 247
2024
Q2 		$1.48M Buy
2,729
+200
+8% +$106K 0.09% 208
2024
Q1 		$1.31M Buy
2,529
+107
+4% +$53.2K 0.09% 221
2023
Q4 		$1.14M Sell
2,422
-76
-3% -$35.1K 0.08% 220
2023
Q3 		$1.09M Buy
2,498
+156
+7% +$70.8K 0.09% 197
2023
Q2 		$1.04M Sell
2,342
-92
-4% -$42.4K 0.09% 204
2023
Q1 		$1.12M Sell
2,434
-823
-25% -$392K 0.1% 185
2022
Q4 		$1.67M Sell
3,257
-40
-1% -$20.3K 0.17% 123
2022
Q3 		$1.5M Sell
3,297
-196
-6% -$93.8K 0.16% 122
2022
Q2 		$1.69M Sell
3,493
-86
-2% -$42.5K 0.18% 114
2022
Q1 		$1.76M Buy
3,579
+1,132
+46% +$517K 0.15% 125
2021
Q4 		$1.13M Buy
2,447
+177
+8% +$74.5K 0.07% 197
2021
Q3 		$846K Sell
2,270
-19
-0.8% -$7.22K 0.06% 226
2021
Q2 		$874K Sell
2,289
-30
-1% -$11.5K 0.06% 221
2021
Q1 		$832K Buy
2,319
+181
+8% +$58.2K 0.06% 219
2020
Q4 		$686K Sell
2,138
-17
-0.8% -$5.22K 0.05% 231
2020
Q3 		$578K Buy
2,155
+5
+0.2% +$1.34K 0.05% 230
2020
Q2 		$565K Sell
2,150
-28
-1% -$7.47K 0.05% 209
2020
Q1 		$495K Buy
2,178
+3
+0.1% +$818 0.06% 203
2019
Q4 		$657K Buy
2,175
+77
+4% +$21.2K 0.06% 205
2019
Q3 		$504K Sell
2,098
-165
-7% -$45.2K 0.05% 235
2019
Q2 		$638K Sell
2,263
-57
-2% -$15.6K 0.06% 202
2019
Q1 		$666K Buy
2,320
+3
+0.1% +$868 0.07% 175
2018
Q4 		$609K Sell
2,317
-379
-14% -$104K 0.07% 170
2018
Q3 		$739K Sell
2,696
-231
-8% -$60K 0.08% 170
2018
Q2 		$696K Sell
2,927
-64
-2% -$14.8K 0.07% 190
2018
Q1 		$657K Sell
2,991
-220
-7% -$51.7K 0.07% 185
2017
Q4 		$722K Sell
3,211
-9
-0.3% -$1.92K 0.07% 194
2017
Q3 		$611K Sell
3,220
-256
-7% -$48.7K 0.07% 215
2017
Q2 		$654K Sell
3,476
-113
-3% -$20.3K 0.08% 185
2017
Q1 		$593K Sell
3,589
-77
-2% -$12.2K 0.07% 212
2016
Q4 		$527K Sell
3,666
-1,881
-34% -$252K 0.07% 230
2016
Q3 		$695K Sell
5,547
-3,452
-38% -$446K 0.09% 181
2016
Q2 		$1.18M Sell
8,999
-1,738
-16% -$238K 0.15% 103
2016
Q1 		$1.49M Buy
10,737
+438
+4% +$58.5K 0.19% 87
2015
Q4 		$1.44M Buy
10,299
+4,092
+66% +$564K 0.16% 92
2015
Q3 		$869K Buy
6,207
+2,581
+71% +$388K 0.12% 148
2015
Q2 		$595K Buy
3,626
+87
+2% +$13.9K 0.07% 218
2015
Q1 		$546K Buy
3,539
+11
+0.3% +$1.57K 0.06% 238
2014
Q4 		$444K Sell
3,528
-9
-0.3% -$1.11K 0.05% 267
2014
Q3 		$423K Sell
3,537
-32
-0.9% -$3.67K 0.05% 290
2014
Q2 		$384K Sell
3,569
-202
-5% -$20.8K 0.04% 308
2014
Q1 		$375K Sell
3,771
-252
-6% -$22.8K 0.04% 315
2013
Q4 		$372K Sell
4,023
-58
-1% -$5.15K 0.04% 331
2013
Q3 		$342K Sell
4,081
-777
-16% -$66.6K 0.04% 333
2013
Q2 		$398K Buy
+4,858
New +$364K 0.05% 284

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Pitcairn's ELV Position: Q4 2025 in Review

Pitcairn sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 1,787 shares — an estimated $577K sold.

Pitcairn first reported a position in ELV in Q2 2013 and held it in 50 quarters. The position peaked at $1.76M in Q1 2022. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Pitcairn reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Pitcairn sold 1,787 Elevance Health shares in Q4 2025, an estimated $577K.
  • Pitcairn first reported a position in Elevance Health in Q2 2013 and held it in 50 quarters.
  • Pitcairn's Elevance Health position peaked at $1.76M in Q1 2022.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Pitcairn's 13F filing for Q4 2025.